Glutathione is described so often as the body's master antioxidant that the phrase has stopped carrying much information. This article sets out what the molecule actually does at the biochemical level, and why it is genuinely awkward to study.
What glutathione is
Glutathione is a tripeptide of glutamate, cysteine and glycine. Its defining feature is an unusual gamma peptide bond between the glutamate side chain and cysteine, rather than the standard alpha linkage found in most peptides. That bond is what protects it from degradation by most peptidases, and it is the reason glutathione persists intracellularly at millimolar concentrations when most peptides would be cleaved within minutes.
The functional group that does the work is the cysteine thiol. Everything interesting about glutathione traces back to that single sulphur atom.
The GSH/GSSG couple
Glutathione exists in two interconverting forms: reduced glutathione (GSH) and the oxidised disulphide dimer (GSSG). Two GSH molecules donate electrons and join via a disulphide bridge to form GSSG; glutathione reductase then regenerates GSH using NADPH.
The ratio between these two forms is the point. In a healthy cell the GSH/GSSG ratio sits heavily in favour of the reduced form, and that ratio functions as a readable index of cellular redox state. It is not simply a measure of how much antioxidant is present. A comprehensive 2024 review in Current Medicinal Chemistry covers the biosynthesis and metabolic handling of the molecule in detail.[1]
Where it sits in redox signalling
Reactive oxygen species were long described purely as damage agents. That framing has shifted considerably. A 2023 review in Archives of Toxicology covers the modern position, in which ROS act as signalling molecules at low concentrations and become damaging only when antioxidant capacity is overwhelmed.[2]
Glutathione participates in that signalling directly through glutathionylation, the reversible attachment of glutathione to protein cysteine residues. This modifies protein function and can be reversed enzymatically, which makes it a genuine regulatory mechanism rather than passive buffering.
Nrf2 and transcriptional control
Glutathione synthesis is not constant. It is regulated largely through the transcription factor Nrf2, which under oxidative conditions is released from its repressor and drives expression of a battery of antioxidant genes, including the enzymes that make glutathione itself. Tonelli and colleagues reviewed this transcriptional architecture in Antioxidants & Redox Signaling.[3]
Relationship to thioredoxin
Glutathione does not operate alone. The thioredoxin system runs in parallel, with overlapping substrates and considerable redundancy. Lu and Holmgren's review in Free Radical Biology and Medicine sets out how the two systems interact.[4] Experimental designs that manipulate one and ignore the other frequently produce confusing results, because the remaining system compensates.
Why it is difficult to work with
Glutathione is one of the more troublesome research materials to handle, for reasons that follow directly from its chemistry:
- It oxidises in air. The free thiol readily oxidises to GSSG on exposure to atmospheric oxygen, particularly in neutral or alkaline solution. A solution left on the bench is no longer the material that was weighed out.
- Trace metals catalyse that oxidation. Copper and iron contamination in buffers accelerates it considerably, which is why chelators appear in many glutathione protocols.
- Measurement is easy to get wrong. Because oxidation continues during sample processing, apparent GSH/GSSG ratios are notoriously sensitive to how quickly and how coldly samples are handled.
Standard handling is storage of the lyophilised solid at −20°C, protected from light and moisture, with reconstitution immediately before use rather than in advance.
What the literature does not establish
Intracellular glutathione concentration and the concentration applied to a culture medium are very different quantities, and the relationship between them is not simple. Glutathione is poorly taken up intact by most cells, which is precisely why so much research effort has gone into precursors and delivery strategies rather than the molecule itself. Any experimental design that assumes applied concentration equals intracellular concentration is making an assumption the literature does not support.
References
- Gasmi A. An Update on Glutathione's Biosynthesis, Metabolism, Functions, and Medicinal Purposes. Current Medicinal Chemistry. 2024. PMID 37921175
- Jomova K. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Archives of Toxicology. 2023. PMID 37597078
- Tonelli C. Transcriptional Regulation by Nrf2. Antioxidants & Redox Signaling. 2018. PMID 28899199
- Lu J. The thioredoxin antioxidant system. Free Radical Biology & Medicine. 2014. PMID 23899494
Research use only
Glutathione is supplied by MMpeptides strictly for laboratory and in vitro research. It is not approved for human or veterinary use, is not a cosmetic or medicinal product, and nothing in this article should be read as describing use in people. Third-party studies are cited for scientific context only. Researchers are responsible for observing all applicable regulations in their jurisdiction.